Back

Cardiovascular-kidney-metabolic overlap and finerenone in heart failure: insights from the FINEARTS-HF Trial

31 August 2026 (14:40 - 14:50)
Organised by: Logo
Congress Presentation Part of: HFpEF: targeting the underlying pathophysiology Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor John Ostrominski

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail
Molecular mechanisms of diastolic heart failure: a study of myosin phosphatase regulatory subunit deficiency
Doctor M. Mccauley (Chicago, US)
Abstract Slides Video
Presentation thumbnail
The classical- and alternative renin-angiotensin-aldosterone-system (RAAS) in HFpEF and cardiac amyloidosis - a cohort comparison of angiotensin profiles
Mr K. Kumar (AT)
Abstract Slides Video
Presentation thumbnail
Characterisation of exercise responses in HFpEF stratified by ejection fraction: implications for therapeutic myosin modulation
Doctor R. Xavier (Oxford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
HFpEF: targeting the underlying pathophysiology
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 14:40 CET
You may be interested in
thumbnail
Congress Presentation
Finerenone
20 May 2025
thumbnail
Congress Presentation
Discussant review - FINE-HEART
13 May 2024
thumbnail
Congress Session
Cardiorenal-metabolic triad: the global health challenge
29 August 2025
thumbnail
Congress Presentation
Transforming CKM syndrome and HFmrEF/HFpEF management: long-term estimated benefits of integrated strategies
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources